The small patient populations of rare diseases, the limited natural history of these conditions, and the lack of long-term experience with new treatments all contribute to the difficulty in determining the value of rare disease therapies. The issue can be further complicated by whether value is calculated in a single payer system, or a multi-payer system. Recently the Innovation and Value Initiative issued a report with the Everylife Foundation for Rare Diseases from a long-term project to bring together stakeholders to explore patient-centered outcomes across rare diseases to inform those discussions. We spoke to Rick Chapman, chief scientific officer of the Innovation and Value Initiative, about the challenges of assessing the value of rare disease therapies, the role qualitative data should play in value assessments, and the recommendations from the report.
Using Genetic Testing to Address Disparities in Care for Kidney Disease
Why Reforms to the Accelerated Approval Pathway Threaten Rare Disease Drug Development
A Longstanding Academic-Nonprofit Collaboration Gives Rise to an ALS Drug Company
Targeting Regulatory RNA to Upregulate Gene Expression to Treat Rare Diseases
Developing a New Approach to Treat Rare, Autoimmune Conditions
Bridging the Gap Between Basic and Commercial Research for Rare Disease
Stoking Functional Copies of Genes to Compensate for Mutated Ones
Targeting ALS with Synergistic Combinations of Therapies
How a Polish Rare Disease Organizations Is Helping Its Ukrainian Neighbors
Powering a New Era of Genetic Medicine
Searching for a Diagnosis
A Novel Way to Deliver Rare Disease Therapies
Bringing Diversity, Equity, and Inclusion to the Books We Read
From Mila to Millions: Scaling N of 1 Therapies
Genetically Modifying Patients’ Skin Cells to Treat Rare Diseases
Targeting Rare, Immunologic Disorders
Harnessing a Natural Mechanism to Silence Disease
Advancing Precision Medicine with Patient Data
Pregnancy and Motherhood for a Woman with SMA
Steps to Improve Data Gathering of Rare Diseases
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money